...version: NeueHealth gets $30M loan increase from NEA, now majority owner (Baffling) This packed week was about righting listing ships. Teladoc’s CEO suddenly departs, Amwell at risk of a NYSE delisting–we look at What Happened and what needs to be done. VillageMD gets new COO to manage the shrinkage. And Change Healthcare data on sale from disgruntled ALPHV affiliate. Digital health funding continues to limp along. Clover looks at another delisting, Walmart Health applies the brakes. And we highlight innovations from Novosound, Biolinq, Eko, Universal Brain. Digital health’s Q1 according to Rock Health: the New Reality is a flat spin... Continue Reading
Search Results for 🐕💗🌭 Viagra super active 100mg - sildenafil citrate samples ↠ 💘 www.USPharm.ORG 🖤♦ . where to order☕✎:Sildenafil citrate - Integrativesleep, viagra super active vs viagra,how to make sildenafil citrate at home,cialis super active,super viagra 200mg,viagra super active reviews
TandemStride launches platform to assist survivors of traumatic injury; a personal look
...brother had a bi-lateral amputation as a college student due to a train accident in 2012. His brother’s injury and recovery had its ups and downs, but he had the important and focused help of his mother, a nurse. This led to Matt looking at others with similar injuries, which are all too common. Psychiatrists, like your Editor’s brother, see many of them in everyday practice. Beyond the physical injuries, there is PTSD coupled with loss of employment and ordinary socialization due to lack of physical ability. One in four have PTSD. But with help, they can overcome. Today, Mark... Continue Reading
ISfTeH student contest and award 2024–deadline 26 April!
...year, in October, the award session will take place, in which the winners (first, second and third place) will receive a cash prize sponsored by ISfTeH member, Medgate. If you are a student, but not yet a student member in the ISfTeH, submit your membership application at www.isfteh.org/members/how_to_join. If you are working at a school or university and would like your students to be involved in the contest, also contact Dr. Simone Farah. Editor Donna would invite our international Readers to keep up with ISfTeH on their website linked above, with member and supported affiliate events from Finland to Nigeria.... Continue Reading
Mid-week short takes: UnitedHealth’s $1.2B Q1 loss from Change attack, another Walgreens layoff, Dexcom-MD Revolution partner, Kontakt.io $47.5 raise, GeBBS Healthcare may sell for $1B
...and clinical spaces around a patient’s care journey. The additional funds will be used for sales expansion and AI development. HIStalk, Release GeBBS Healthcare Solutions on the block, may fetch $1 billion. The LA-based business process outsourcing (BPO)/revenue cycle management (RCM) company, currently owned by ChrysCapital of New Delhi, is on the market for a reported $800 million to $1 billion. This would be a tidy payday for ChrysCapital which back in 2018 acquired an 80% stake in GeBBS for $140 million with a valuation then of $175 million. ChrysCapital is India’s largest home-grown PE investor. Economic Times-India Times, HIStalk... Continue Reading
TTA’s April Showers 2: Teladoc, Amwell’s future, VillageMD’s new COO, Change data on sale, digital health funding limps along, pending delistings, innovations sprout, more!
This packed week is about righting listing ships. Teladoc’s CEO suddenly departs, Amwell at risk of a NYSE delisting–we look at What Happened and what needs to be done. VillageMD gets new COO to manage the shrinkage. And Change Healthcare data on sale from disgruntled ALPHV affiliate. Digital health funding continues to limp along. Clover looks at another delisting, Walmart Health applies the brakes. And we highlight innovations from Novosound, Biolinq, Eko, Universal Brain. Digital health’s Q1 according to Rock Health: the New Reality is a flat spin back to 2019 (Limping, but alive) VillageMD names new president... Continue Reading
Digital health’s Q1 according to Rock Health: the New Reality is a flat spin back to 2019
...the value for their investment. And funders will scrutinize x 3. Companies, unable to satisfy public shareholders so easily pleased in the SPAC and IPO palmy days of 2021-23, are leaving, not entering, public markets. Veradigm had to delist this year because of Nasdaq financial reporting problems from bad software despite being financially healthy–and acquiring ScienceIO. Rock Health does not include the recent pending delistings of Clover Health and Amwell. Both NextGen Healthcare and SOC Telemed went private last year. Others were acquired: Science 37, BenefitFocus, Castlight, Signify Health, and Tabula Rasa. Four went out of business: Babylon Health (Ch.... Continue Reading
VillageMD names new president and COO as it shrinks to 620 locations
...on 29 March, just in time to move to VillageMD. His planned retirement was announced by Centene last May. Previously, he had been president and chief operating officer at Magellan Health from January 2020 to its acquisition by Centene in January 2022. Subsequently, Centene sold parts of Magellan such as Specialty Health and Rx. His experience crosses both provider and payer, at Dallas-based PrimeWest Health, the Dallas-based hospital system LifeCare Health Partners, and prior to that, 28 years at Humana, departing as chief operating officer. It does show one how close the circles are at the C-level. St. Louis Today... Continue Reading
News roundup: Now Clover Health faces delisting; BlackCat/ALPHV affiliate with 4TB of data puts it up for sale; $58M for Biolinq’s ‘smallest blood glucose biosensor’
Clover Health takes another pass at Nasdaq delisting. Once again, Clover’s Class A shares (CLOV) have been trading with an average closing price of below $1.00 over a consecutive 30 trading-day period, which violates Nasdaq’s continued listing minimum price criteria for the Nasdaq Global Select Market. This was announced in their most recent 8-K filed with the SEC 2 April. Clover has until 30 September to remedy the situation. An additional 180-day period may be elected if Clover transfers to the Nasdaq Capital Market. FierceHealthcare, Becker’s The delisting is a rerun of their situation last year at this time. Clover... Continue Reading
Opinion: Further thoughts on Teladoc, Amwell, and the future of telehealth–what happens next?
...But Wentworth has moved quickly, decisively, and positioned it realistically in saying ‘this is not a 12-month turnaround’ and wisely caveating that board alignment around the strategic review was essential. Timid he is not. Teladoc needs to move quickly, and intelligently–now, not later. While acting CEO Mala Murthy, backed by the board, makes decisive moves, Teladoc must find and appoint a Tim Wentworth-type at the helm for the turnaround. Quickly. It’s important not only for Teladoc but also for the telehealth industry. But neither Mr. Market, judging on share price, nor this Editor, based on their track record, are hopeful.... Continue Reading
TTA’s April Showers: NeueHealth’s big loss + big CEO bonus, Cano Health’s reorg update, Davids keep facing the Apple Goliath, ATA presses DOJ on controlled substance telehealth, advice on working with PR, more!
A damp start to April leads with puzzling news. NeueHealth loses plans and big money in ’23–but gives a big bonus to its CEO. Cano Health reorganizing or selling by June. ATA kicks DOJ about expediting controlled substance telehealth regs. Apple keeps kicking around the ‘Davids’, but they won’t stop either. And if you work with a PR or marketing agency, our Perspectives has some advice for you. More New Reality: NeueHealth (Bright Health) CEO’s $1.9M bonus, 2023 financials–and does Cano Health have a future? (Two stories gone way sideways) ATA requests expediting of revised proposed rule on... Continue Reading
Most Recent Comments